Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending April 1, 2018
Right-to-try bill advances in Congress, The Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right To Try Act of 2018 (H.R. 5247)
Best states to practice medicine are in the upper Midwest, Published online March 27 at https://wallethub.com/edu/best-and-worst-states-for-doctors/11376/#
Socioeconomic status did not predict survival in NSCLC patients with cachexia, Lau S et al. JOP published online March 20 https://doi.org/10.1200/JOP.2017.025239
Integrated delivery network did not cut costs of care, Kaye D et al. Journal of Oncology Practice 2018 14:3, e149-e157.
Payer-sponsored program cut costs, had high patient satisfaction, Hoverman J et al. JOP published online March 16 https://doi.org/10.1200/JOP.17.00091
Must reads for theWeek ending March 25, 2018
LVADs as destination therapy, Mehra MR et al. New Engl J Med DOI: 10.1056/NEJMoa1800866.
Treatment-free remission in CML, Mahon FX et al. Ann Intern Med. 2018 Feb 20. doi: 10.7326/M17-1094.
Anticoagulation linked to low BMD in children, Patel KN et al. Thrombosis & Hemostasis Societies of North America 2018, Poster 65.
New option for chronic graft vs. host, Lazaryan A et al. 2018 BMT Tandem Meetings, Abstract 38.
In myeloma, go for a third transplant, Garderet L et al. Biol Blood Marrow Transplant. 2018 Feb 3. doi: 10.1016/j.bbmt.2018.01.035
Must reads for theWeek ending March 18, 2018
How do you pronounce that drug name?, Frank D. JAMA Intern Med. 2018;178(3):319-320. doi:10.1001/jamainternmed.2017.7898
'Glass ceiling' extends to biomedical industry payments, Tringale K and Hattangadi-Gluth J. JAMA Intern Med. 2018;178(3):421-423. doi:10.1001/jamainternmed.2017.7445
Mining social media to detect adverse drug reactions to newly-approved drugs, Ransohoff J et al. JAMA Oncology March 1, 2018. doi:10.1001/jamaoncol.2017.5688
Insurance type linked to cancer care delays, Wharam et al. J Clin Oncol. 2018 Feb 28. doi: 10.1200/JCO.2017.75.2501.
Intervention boosted the rate of colorectal cancer screening, Source: Miller, D et al. Ann Inter Med 2018. DOI: 10.7326/M17-2315
Must reads for theWeek ending March 11, 2018
Six factors predict urothelial cancer response, Pond GR et al. GU Cancers Symposium Abstract 413
Combo bests single therapy in metastatic RCC, Motzer RJ et al. GU Cancers Symposium Abstract 578
Chemo is best course in resected urothelial disease, Birtle A et al. Genitourinary Cancers Symposium. Abstract 407.
Selecting chemoradiation in bladder cancer, Coen, J. et al, 2018 Genitourinary Cancers Symposium, Abstract 408.
When to choose surgery or surveillance in RCC, Hakimi A et al. J Urol. 2018 Feb 26 doi: 10.1016/j.juro.2018.02.3087.
Must reads for theWeek ending March 4, 2018
SPK-9001 prevented bleeding, need for exogenous factors in hemophilia B, N Engl J Med. 2017;377[23]:2215-27
Potential universal infusion products for sickle cell disease, Chou S et al. ASH 2017 Abstract 3
BMN 270 eliminated spontaneous bleeds in patients with hemophilia A, Pasi KJ et al. ASH 2017 Abstract 603
Gene therapy cut need for blood transfusions in beta thalassemia, Marktel S et al. ASH 2017 Abstract 355
Successful Waldenström macroglobulinemia therapy may also resolve acquired VWD, Source: Castillo J, et al. ASH 2017 Abstract 1088.